Literature DB >> 18387360

Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study.

Shafiq U Rehman1, Abelardo Martinez-Rumayor, Thomas Mueller, James L Januzzi.   

Abstract

BACKGROUND: Acute dyspnea is common in the emergency department (ED) and is associated with mortality. Biomarkers may help stratify risk in this setting.
METHODS: Among 577 dyspneic subjects we identified 5 candidate biomarkers with prognostic value: amino terminal B-type natriuretic peptide (NT-proBNP), C-reactive protein (CRP), the interleukin family member ST2, hemoglobin and blood urea nitrogen (BUN); these were assessed using both receiver operating characteristic curve and Cox proportional hazards analyses. Results were validated in a population of dyspneic patients from a distinct cohort.
RESULTS: At 1 y follow up, 93 (16.1%) patients had died. Independent predictive ability was established in an age-adjusted Cox model containing all markers: NT-proBNP (HR=1.89); CRP (HR=1.95); ST2 (HR=7.17); hemoglobin (HR=1.68); BUN (HR=2.06) (all P<.05). Following categorical assessment based on number of abnormal markers, the 1-y risk of death increased in a monotonic fashion with mortality rates of 0%, 2.0%, 7.8%, 22.3%, 29.3%, and 57.6% respectively; similar results were seen in the validation set.
CONCLUSION: Simultaneous assessment of pathophysiologically diverse markers in acute dyspnea provides powerful, independent and incremental prognostic information.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18387360     DOI: 10.1016/j.cca.2008.03.002

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  13 in total

1.  Elevated blood urea nitrogen and medical outcome of psychiatric inpatients.

Authors:  Peter Manu; Zainab Al-Dhaher; Sameer Khan; John M Kane; Christoph U Correll
Journal:  Psychiatr Q       Date:  2014-03

2.  Midrange ejection fraction as a risk factor for deterioration of cardiofunction after permanent pacemaker implantation.

Authors:  Hua He; XiaoDong Li; BingBing Ke; Zhuo Chen; FuSheng Han; YuJie Zeng
Journal:  J Interv Card Electrophysiol       Date:  2019-02-09       Impact factor: 1.900

Review 3.  Use of multiple biomarkers in heart failure.

Authors:  Larry A Allen
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

4.  Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial.

Authors:  Quynh A Truong; Emily Siegel; Mahir Karakas; James L Januzzi; Fabian Bamberg; Amir A Mahabadi; Selcuk Dasdemir; Thomas J Brady; Andreas Bergmann; Jan Kunde; John T Nagurney; Udo Hoffmann; Wolfgang Koenig
Journal:  Clin Chem       Date:  2010-02-25       Impact factor: 8.327

5.  Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.

Authors:  Jozef Bartunek; Leen Delrue; Frederik Van Durme; Olivier Muller; Filip Casselman; Bart De Wiest; Romaric Croes; Sofie Verstreken; Marc Goethals; Herbert de Raedt; Jaydeep Sarma; Lija Joseph; Marc Vanderheyden; Ellen O Weinberg
Journal:  J Am Coll Cardiol       Date:  2008-12-16       Impact factor: 24.094

Review 6.  Multi-marker strategies in heart failure: clinical and statistical approaches.

Authors:  Larry A Allen; G Michael Felker
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

7.  Role of IL-33 in inflammation and disease.

Authors:  Ashley M Miller
Journal:  J Inflamm (Lond)       Date:  2011-08-26       Impact factor: 4.981

8.  Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study.

Authors:  Mihael Potocki; Tobias Breidthardt; Tobias Reichlin; Nils G Morgenthaler; Andreas Bergmann; Markus Noveanu; Nora Schaub; Heiko Uthoff; Heike Freidank; Lorenz Buser; Roland Bingisser; Michael Christ; Alexandre Mebazaa; Christian Mueller
Journal:  Crit Care       Date:  2009-07-23       Impact factor: 9.097

9.  ProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study.

Authors:  Bo K Lauridsen; Kasper Iversen; Ingrid Hunter; Morten Bay; Vibeke Kirk; Olav W Nielsen; Henrik Nielsen; Søren Boesgaard; Lars Køber; Jens P Goetze
Journal:  BMJ Open       Date:  2013-11-25       Impact factor: 2.692

10.  Association between N-terminal Pro-Brain Natriuretic Peptide levels, glomerular filtration rate, and heart failure in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Daneyal Syed; Stephanie Peshenko; Kiang Liu; Ramon Durazo-Arvizu; Sylvia E Rosas; Michael Shlipak; Mark Sarnak; David Jacobs; David Sickovick; João Lima; Richard Kronmal; Holly Kramer
Journal:  J Integr Cardiol       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.